Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution

THE cell-surface glycoprotein vascular cell adhesion molecule-1 (VCAM-1; ref. 1) mediates intercellular adhesion2 by specific binding to the integrin very-late antigen-4 (VLA-4, α4β1; ref. 3). VCAM-1, with the intercellular adhesion molecules ICAM-1, ICAM-2, ICAM-3 and the mucosal vascular addressin MAd-CAM-1, forms an integrin-binding subgroup of the immuno-globulin superfamily. In addition to their clinical relevance in inflammation, these molecules act as cellular receptors for viral and parasitic agents2. The predominant form of VCAM-1 in vivo has an ammo-terminal extracellular region comprising seven immunoglobulin-like domains. Functional studies4-7 have identified a conserved integrin-binding motif in domains 1 and 4, variants of which are present in the N-terminal domain of all members of the immunoglobulin superfamily subgroup. We report here the crystal structure of a VLA-4-binding fragment composed of the first two domains of VCAM-1. The integrin-binding motif (Q38IDSPL) is highly exposed and forms the N-terminal region of the loop between β-strands C and D of domain 1. This motif exhibits a distinctive conformation which we predict will be common to all the integrin-binding IgSF molecules. These, and additional data, map VLA-4 binding to the face of the CFG β-sheet, the surface previously identified8 as the site for intercellular adhesive interactions between members of the immunoglobulin superfamily.

[1]  M. Elices,et al.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.

[2]  D I Stuart,et al.  Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. , 1979, Journal of molecular biology.

[3]  M. Humphries,et al.  Expression and characterisation of a very-late antigen-4 (alpha 4 beta 1) integrin-binding fragment of vascular cell-adhesion molecule-1. , 1994, European journal of biochemistry.

[4]  Richard Axel,et al.  Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution , 1992, Cell.

[5]  M. Humphries,et al.  The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. , 1991, The Journal of biological chemistry.

[6]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[7]  C Chothia,et al.  Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. , 1994, Journal of molecular biology.

[8]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[9]  L. Presta,et al.  Structural requirements for adhesion of soluble recombinant murine vascular cell adhesion molecule-1 to alpha 4 beta 1 , 1994, The Journal of cell biology.

[10]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[11]  Michael Loran Dustin,et al.  The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus , 1990, Cell.

[12]  A. Brass,et al.  Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. , 1994, Journal of cell science.

[13]  David I. Stuart,et al.  Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2 , 1992, Nature.

[14]  D. Staunton,et al.  Residues within a conserved amino acid motif of domains 1 and 4 of VCAM- 1 are required for binding to VLA-4 , 1994, The Journal of cell biology.

[15]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[16]  L M Amzel,et al.  Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 A resolution. , 1981, The Journal of biological chemistry.

[17]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[18]  D. Stuart,et al.  Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. , 1994, Structure.

[19]  D. Stuart,et al.  Structure of a major immunogenic site on foot-and-mouth disease virus , 1993, Nature.

[20]  H M Holden,et al.  X-ray structure determination of telokin, the C-terminal domain of myosin light chain kinase, at 2.8 A resolution. , 1992, Journal of molecular biology.

[21]  W A Hendrickson,et al.  Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. , 1992, Science.

[22]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[23]  R. Cobb,et al.  Cyclic RGD peptide inhibits alpha 4 beta 1 interaction with connecting segment 1 and vascular cell adhesion molecule. , 1994, The Journal of biological chemistry.

[24]  Jones Ta,et al.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. , 1985, Methods in enzymology.

[25]  T. Kirchhausen,et al.  Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1) , 1994, The Journal of cell biology.

[26]  Peter D. Kwong,et al.  Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.